Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 17, 2023Research Article

Association of Brain Atrophy With Functional Outcome and Recovery Trajectories After Thrombectomy: Post-Hoc Analysis of the ESCAPE-NA1 Trial

Faysal Benali, Joachim Fladt, View ORCID ProfileTanaporn Jaroenngarmsamer, View ORCID ProfileFouzi Bala, Nishita Singh, Johanna Maria Ospel, Michael Tymianski, View ORCID ProfileMichael D. Hill, Mayank Goyal, View ORCID ProfileAravind Ganesh
First published August 17, 2023, DOI: https://doi.org/10.1212/WNL.0000000000207700
Faysal Benali
1Maastricht University Medical Center+ (MUMC+)
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Fladt
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanaporn Jaroenngarmsamer
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tanaporn Jaroenngarmsamer
Fouzi Bala
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fouzi Bala
Nishita Singh
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Maria Ospel
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Tymianski
3NoNO, Toronto, ON, Canada
MD PhD FRCSC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Hill
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD MSc FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael D. Hill
Mayank Goyal
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aravind Ganesh
2Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aravind Ganesh
  • For correspondence: aganesh@ucalgary.ca
Full PDF
Citation
Association of Brain Atrophy With Functional Outcome and Recovery Trajectories After Thrombectomy: Post-Hoc Analysis of the ESCAPE-NA1 Trial
Faysal Benali, Joachim Fladt, Tanaporn Jaroenngarmsamer, Fouzi Bala, Nishita Singh, Johanna Maria Ospel, Michael Tymianski, Michael D. Hill, Mayank Goyal, Aravind Ganesh
Neurology Aug 2023, 10.1212/WNL.0000000000207700; DOI: 10.1212/WNL.0000000000207700

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
27

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Background and Objectives Brain frailty may impair the ability of acute stroke patients to cope with the injury, irrespective of their chronological age, resulting in impaired recovery. We aim to investigate the impact of brain atrophy on functional outcome assessed at different time points after EVT.

Methods In this retrospective post-hoc analysis of the ESCAPE-NA1-trial, we analyzed CT-imaging data for cortical atrophy by using the GCA-scale, including region-specific scales, and subcortical atrophy by using the intercaudate-distance-to-inner-table-width (CC/IT)- ratio. The primary outcome was 90-day-mRS (ordinal-shift-analysis) and the secondary outcome was the mRS-score over time. Adjustments were made for age, sex, baseline-NIHSS, final infarct volume, stroke laterality, total Fazekas score and nerinetide-alteplase interaction. Sensitivity analyses were additionally performed in only those patients for whom MRI-data were available.

Results Out of 1,102 participants (mean age of 69.5±13.7 years;554 men), 818 (74%) had GCA=0, 220 (20%) had GCA=1 and 64 (6%) GCA=2/3. The median CC/IT-ratio was 0.12(IQR0.10-0.15). Cortical atrophy(GCA≥1 vs GCA-0) was associated with worse 90-day-mRS (acOR=1.62[95%CI:1.22-2.16]; p=001), lower rates of 90-day-mRS0-2 (aOR=0.65[95%CI:0.45-0.94]; p=0.022) and higher mortality (aOR=2.12[95%CI:1.28-3.5]; p=0.003), regardless of the region assessed. Subcortical atrophy was associated with worse 90-day-mRS(acOR[per 0.01 increase in CC/IT-ratio]=1.07[95%CI:1.04-1.11]; p<0.001) and lower rates of 90-day mRS0-2(aOR=0.92[95%CI:0.88-0.97]; p=0.001). Furthermore, with various degrees of atrophy, we observed heterogeneity in mRS-measurements during follow-up: worse mRS scores for higher atrophy grades(p<0.001). Compared to participants with GCA=0, the mRS for participants with GCA=1 was higher at 30-days (adjusted-difference=0.41[95%CI:0.18-0.65]) and remained worse at 90-days (adjusted-difference=0.72[95%CI:0.49-0.95]). Similar effects were seen for participants with worse cortical atrophy, regardless of the region assessed, and worse subcortical atrophy. Furthermore, 26/63(41%) and 124/274(45%) of patients with severe cortical/subcortical atrophy (GCA-2/-3 and highest CC/IT-ratio quartile, respectively) achieved good functional outcome(mRS0-2), compared to 539/812(66.4%) with no cortical atrophy and 209/274(76%) in the lowest CC/IT-ratio quartile.

Discussion In this large RCT-derived population, participants with brain atrophy, as visually assessed on acute NCCT-imaging, showed less favorable stroke recovery after EVT and worse 90-day functional outcomes compared to participants without brain atrophy. This may support physicians with recovery expectations when planning post-EVT care with patients and their families.

  • Received October 1, 2022.
  • Accepted in final form June 9, 2023.
  • © 2023 American Academy of Neurology

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

Dr. Ann Yeh and Dr. Daniela Castillo Villagrán

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Cerebrovascular disease/Stroke
  • CT
  • MRI
  • Stroke prevention
  • Other cerebrovascular disease/ Stroke

Alert Me

  • Alert me when eletters are published
Neurology: 101 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise